Health Care [ 4/12 ] | Pharmaceuticals [ 14/72 ]
NASDAQ | Common Stock
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products.
The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure.
Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms.
The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device.
The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 14, 24 | -0.36 Decreased by -20.00% | -0.44 Increased by +18.18% |
| Mar 13, 24 | -0.35 Decreased by -16.67% | -0.42 Increased by +16.67% |
| Nov 8, 23 | -0.41 Decreased by -10.81% | -0.36 Decreased by -13.89% |
| Aug 10, 23 | -0.36 Decreased by -2.86% | -0.37 Increased by +2.70% |
| May 10, 23 | -0.30 Decreased by -7.14% | -0.36 Increased by +16.67% |
| Mar 22, 23 | -0.30 Decreased by -11.11% | -0.39 Increased by +23.08% |
| Nov 9, 22 | -0.37 Decreased by -54.17% | -0.38 Increased by +2.63% |
| Aug 9, 22 | -0.35 Decreased by -34.62% | -0.30 Decreased by -16.67% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 3.80 M Increased by +N/A% | -15.63 M Decreased by -51.36% | Decreased by -411.85% Decreased by N/A% |
| Jun 30, 23 | 1.64 M Increased by +N/A% | -14.15 M Decreased by -41.92% | Decreased by -864.10% Decreased by N/A% |
| Mar 31, 23 | 2.06 M Increased by +N/A% | -12.83 M Decreased by -56.01% | Decreased by -621.76% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -9.76 M Decreased by -33.40% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -10.33 M Decreased by -57.65% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -9.97 M Decreased by -41.22% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -8.22 M Decreased by -15.77% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -7.32 M Increased by +5.99% | Decreased by N/A% Decreased by N/A% |